Expiring federal contract · order under a contract vehicle
75H71025F80116 — Roche Diabetes Care INC
Department of Health and Human Services · Indian Health Service
- Contract / PIID
- 75H71025F80116
- Incumbent
- Roche Diabetes Care INC
- Incumbent UEI
- F6JDDN8L9JM4
- Current end date
- March 31, 2027
- Potential total value
- $244,000
- Obligated
- $244,000
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6515 — MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Set-aside
- Not stated
- Start date
- March 24, 2025
- Place of performance
- IN
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
FY 25 ROCHE DIABETES CARE BPA - MEDICAL SUPPLY
Likely rebid window (estimate)
- Sources Sought / RFI: about Mar 2026 – Sep 2026 (6–12 months before the end date)
- RFP: about Nov 2026 – Jan 2027 (2–4 months before the end date)
Between the estimated Sources Sought and RFP windows.
This is an order under contract vehicle V797D50597. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325413)
- 75H71025P00975 — Becton, Dickinson And Company · ends November 30, 2026 · $103K
- 75H71226F28022 — Cepheid · ends January 11, 2027 · $460K
- 75N90026P00079 — Werfen USA LLC · ends January 31, 2027 · $170K
- 75H71226F28026 — Cepheid · ends February 7, 2027 · $272K
- 75H71226F28010 — Biomerieux INC · ends February 26, 2027 · $240K
- 75H70722P00094 — Cepheid · ends February 28, 2027 · $2.8M
- 75H70723F80016 — Abbott Laboratories INC. · ends February 28, 2027 · $310K
- 75H71226F28027 — Cepheid · ends April 14, 2027 · $600K
- 75H70726F80013 — Fisher Scientific Company L.L.C. · ends April 30, 2027 · $610K
- 75A50123C00036 — Siro Diagnostics, INC. · ends May 1, 2027 · $28M